세계의 방사선량 관리(RDM) 시장 : 제공별, 모달리티별, 수익 모델별, 용도별, 최종 사용자별 - 예측(2025-2030년)

The Radiation Dose Management Market was valued at USD 796.02 million in 2023, expected to reach USD 904.45 million in 2024, and is projected to grow at a CAGR of 14.06%, to USD 1,999.40 million by 2030.

Radiation Dose Management (RDM) encompasses systems and strategies designed to monitor, control, and report the amounts of radiation doses administered to patients undergoing diagnostic imaging and therapeutic procedures. Its necessity arises from increasing awareness about the health risks associated with radiation exposure, driving healthcare providers to mitigate potential overdoses and adhere to safety standards. The application spans across numerous fields, with significant end-use in hospitals, diagnostic imaging centers, and nuclear medicine facilities where radiological procedures are routine. Market growth will likely derive from technological advancements in imaging modalities, stringent regulatory policies mandating dose monitoring, and a growing patient pool undergoing diagnostic and interventional radiology, especially in developed economies.

Key growth influencers include technological integration, like AI and machine learning, leading to the development of sophisticated dose management systems enhancing efficiency and accuracy. Additionally, rising healthcare expenditure and the adoption of electronic health records (EHR) boost the need for comprehensive RDM systems. Nevertheless, market growth faces challenges from high initial setup costs for RDM solutions, a shortage of skilled professionals to operate advanced systems, and data privacy concerns amidst increasing cyber threats.

Potential opportunities lie in emerging markets with growing healthcare infrastructure investments. Expanding cloud solutions provide scalable RDM systems, facilitating easier adoption for smaller clinics and remote healthcare providers. Collaboration with healthcare IT companies to enhance interoperability between different RDM and EHR systems can also unlock opportunities. Innovations may focus on real-time dose optimization and patient-specific customization, providing precise management that reduces unnecessary exposure while maintaining diagnostic quality.

The market is increasingly competitive, with vendors striving for technological breakthroughs in AI-enhanced RDM tools and improved user interfaces for seamless integration into existing healthcare infrastructures. To maintain competitiveness, businesses should focus on R&D initiatives for smarter dose metrics and analytics, thus providing value-added services that increase the precision and safety of radiological procedures.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Radiation Dose Management Market

The Radiation Dose Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Awareness of the potential risks associated with radiation exposure in medical imaging
  • Rising investments to set up X-rays, CT scans, and fluoroscopies in hospitals
• Market Restraints
  • Complications in the implementation of advanced RDM systems
• Market Opportunities
  • Advancements in radiation dose management devices
  • Shift toward digital health records and need for comprehensive RDM systems
• Market Challenges
  • Operational limitations and technical errors of EDM systems

Porter's Five Forces: A Strategic Tool for Navigating the Radiation Dose Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Radiation Dose Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Radiation Dose Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Radiation Dose Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Radiation Dose Management Market

A detailed market share analysis in the Radiation Dose Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Radiation Dose Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Radiation Dose Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Radiation Dose Management Market

A strategic analysis of the Radiation Dose Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Radiation Dose Management Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Agfa-Gevaert Group, Bayer AG, Bracco S.p.A., Canon Inc., Dedalus S.p.A., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Guerbet, IBA Dosimetry GmbH, Imalogix, Infinitt Healthcare Co Ltd, Koninklijke Philips N.V., LANDAUER, Inc., McKesson Corporation, Medic Vision Imaging Solutions, Medsquare, Medsquare SAS, Mirion Technologies, Inc, Novarad, Novarad Corporation, PACSHealth, LLC, Qaelum NV, Sectra AB, Siemens Healthineers AG, SST Group Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Radiation Dose Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Services and Software. The Software is further studied across Integrated and Standalone.
• Based on Modality, market is studied across Computed Tomography, Fluoroscopy & Interventional Imaging, Imaging, and Mammography.
• Based on Revenue Model, market is studied across Annual Purchase and Pay-Per Procedure.
• Based on Application, market is studied across Cardiology, Oncology, Orthopedic, and Radiography.
• Based on End-User, market is studied across Ambulatory Care Setting, Hospitals, and Research Institutes & Academic Medical Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Awareness of the potential risks associated with radiation exposure in medical imaging
    • 5.1.1.2. Rising investments to set up X-rays, CT scans, and fluoroscopies in hospitals
  • 5.1.2. Restraints
    • 5.1.2.1. Complications in the implementation of advanced RDM systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in radiation dose management devices
    • 5.1.3.2. Shift toward digital health records and need for comprehensive RDM systems
  • 5.1.4. Challenges
    • 5.1.4.1. Operational limitations and technical errors of EDM systems
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Advancement in the softwares offer the seamless diagnostic operations in the hospitals
  • 5.2.2. Modality: Regular quality control checks of different modalities, accurate positioning employed to ensure minimal exposure while achieving reliable diagnostic results
  • 5.2.3. Revenue Model: Pay-Per-Procedure model is more cost-effective and beneficial to the radiation dose management
  • 5.2.4. Application: Radiation dose management has diverse applications in Oncological research and treatments.
  • 5.2.5. End-Use: Hospitals advanced management tools to emphasize on precision and reproducibility in their dose management protocols
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Radiation Dose Management Market, by Offering

• 6.1. Introduction
• 6.2. Services
• 6.3. Software
  • 6.3.1. Integrated
  • 6.3.2. Standalone

7. Radiation Dose Management Market, by Modality

• 7.1. Introduction
• 7.2. Computed Tomography
• 7.3. Fluoroscopy & Interventional Imaging
• 7.4. Imaging
• 7.5. Mammography

8. Radiation Dose Management Market, by Revenue Model

• 8.1. Introduction
• 8.2. Annual Purchase
• 8.3. Pay-Per Procedure

9. Radiation Dose Management Market, by Application

• 9.1. Introduction
• 9.2. Cardiology
• 9.3. Oncology
• 9.4. Orthopedic
• 9.5. Radiography

10. Radiation Dose Management Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Care Setting
• 10.3. Hospitals
• 10.4. Research Institutes & Academic Medical Centers

11. Americas Radiation Dose Management Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Radiation Dose Management Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Radiation Dose Management Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Qaelum NV and Philips Forge Global Strategic Partnership to Advance Radiation Dose Management Solutions
  • 14.3.2. Alara Offers Free Software for MPFS CT Radiation Dose Compliance
  • 14.3.3. Researchers Develop Capsule X-ray Dosimeter for Real-Time Radiotherapy Monitoring
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accuray Incorporated
• 2. Agfa-Gevaert Group
• 3. Bayer AG
• 4. Bracco S.p.A.
• 5. Canon Inc.
• 6. Dedalus S.p.A.
• 7. Fujifilm Holdings Corporation
• 8. GE HealthCare Technologies, Inc.
• 9. Guerbet
• 10. IBA Dosimetry GmbH
• 11. Imalogix
• 12. Infinitt Healthcare Co Ltd
• 13. Koninklijke Philips N.V.
• 14. LANDAUER, Inc.
• 15. McKesson Corporation
• 16. Medic Vision Imaging Solutions
• 17. Medsquare
• 18. Medsquare SAS
• 19. Mirion Technologies, Inc
• 20. Novarad
• 21. Novarad Corporation
• 22. PACSHealth, LLC
• 23. Qaelum NV
• 24. Sectra AB
• 25. Siemens Healthineers AG
• 26. SST Group Inc.
• 27. Thermo Fisher Scientific Inc.